Lorbrena
NDC 63539-927, lorlatinib, tablet, film coated, from U.S. Pharmaceuticals.
- Product NDC
- 63539-927
- Status
- Listed
- Labeler
- U.S. Pharmaceuticals
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210868
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63539-927 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LORLATINIB25 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]; Organic Cation Transporter 1 Inhibitors [MoA]; P-Glycoprotein Inducers [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63539-927-01 | 63539092701 | 30 TABLET, FILM COATED in 1 BOTTLE (63539-927-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/004f93d7-a1cd-4b67-9207-31cdcb5c5976
Use it
Look up 63539-927 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63539-927 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63539-927. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.